SGLT2 Inhibitor Use Not Tied to Increased Fracture Risk in C

WEDNESDAY, June 1, 2022 (HealthDay News) -- For older adults, initiation of a sodium-glucose cotransporter-2 (SGLT2) inhibitor is not associated with higher fracture risk compared with initiation of a dipeptidyl

Related Keywords

United States , Canada , London , City Of , United Kingdom , American , Andrea Cowan , Evaluative Sciences , Institute For Clinical , Healthday News , Clinical Journal , American Society , ,